---
title: "160 Series B Healthtech Investors (Nov 2026)"
last_updated: "2026-11-09"
rows: "160"
free_rows: "25"
source: "SEC Form D filings and our own research"
canonical: "https://theinvestordatabase.com/lists/series-b-healthtech-investors/"
---

# 160 Series B healthtech investors

We list 160 Series B healthtech investors as of November 2026: 69 have an SEC filing on file and 91 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The states with the most are California (22), New York (10) and Massachusetts (7).

- 160 investors
- 80 with a fund filing or dated deal in the last 12 months
- $87M median fund size on file (SEC Form D, 48 firms)
- 823 named decision-makers on file

## First 25 of 160 Series B healthtech investors

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| Innovation Industries | VC firm | Amsterdam, Netherlands | Series A, Series B, Growth | Healthtech, Deep Tech, AI, Food and Beverage | New fund, Oct 2026 | €1.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/innovation-industries-capital-partners-b-v/ |
| Claret Capital Partners | Venture debt | London, United Kingdom | Series B, Growth, Late stage | Healthtech, Biotech, Climate Tech, SaaS | New deal, Oct 2026 | €575M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/claret-capital-partners/ |
| Alpha Partners | VC firm | New York, NY | Series B, Growth | Healthtech, AI, Developer Tools, Cybersecurity | New fund, Oct 2026 | $200M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/alpha-partners/ |
| BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Healthtech, Edtech, Developer Tools, Mobility | Portfolio news, Oct 2026 | £3.0B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/bgf/ |
| Cathay Innovation | VC firm | Paris, France | Seed, Series A, Series B, Growth, Late stage | Healthtech, AI, Robotics, Fintech | Portfolio news, Aug 2026 | €2.5B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/cathay-innovation/ |
| Greycroft | VC firm | New York, NY | Series A, Series B, Growth | Healthtech, AI, Industrial Tech, Defense Tech | New deal, Oct 2026 | $600M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/greycroft/ |
| Balderton Capital | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Healthtech, AI, Fintech, Developer Tools | Portfolio news, Oct 2026 | $5.7B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/balderton-capital/ |
| HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Healthtech, Biotech, Medtech | Portfolio news, Oct 2026 | $2.8B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hbm-partners-ag/ |
| True Beauty Ventures | VC firm | Palm Beach Gardens, FL | Seed, Series A, Series B | Healthtech, Consumer, CPG | New fund, Oct 2026 | $308M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/true-beauty-ventures/ |
| Parkwalk Advisors | SEIS/EIS fund | London, United Kingdom | Seed, Series A, Series B, Growth | Healthtech, AI, Industrial Tech, Energy | New fund, Sep 2026 | £500M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/parkwalk/ |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Healthtech, Biotech, Medtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/andera-partners/ |
| OneTarget | VC firm | Berlin, Germany | Seed, Series A, Series B, Growth | Healthtech, AI, Fintech, Consumer | Portfolio news, Sep 2026 | $3.0B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/onetarget/ |
| Kibo Ventures | VC firm | Spain | Seed, Series A, Series B | Healthtech, Generalist, SaaS, Cybersecurity | New fund, Oct 2026 | €500M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/kibo-ventures-partners-sgeic-s-a/ |
| Menlo Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Series B, Growth | Healthtech, AI, Media, Robotics | New fund, Sep 2026 | $800M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/menlo-ventures/ |
| Translink Capital | VC firm | Palo Alto, CA | Seed, Series A, Series B | Healthtech, AI, Developer Tools, Mobility | New fund, Sep 2026 | $174M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/translink-capital/ |
| Capricorn Partners | VC firm | Leuven, Belgium | Seed, Series A, Series B, Growth | Healthtech, Deep Tech, Climate Tech, SaaS | Portfolio news, Oct 2026 | €300M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/capricorn-partners-nv/ |
| Bison Ventures | VC firm | San Francisco, CA | Pre-seed, Seed, Series A, Series B | Healthtech, AI, Energy, Biotech | New fund, Oct 2026 | $160M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/bison-ventures/ |
| Hadean Ventures | VC firm | Norway | Seed, Series A, Series B | Healthtech, Biotech, Medtech | New deal, Sep 2026 | €230M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hadean-ventures-as/ |
| IVP: Venture capital for the Exceptional | VC firm | Menlo Park, CA | Series B, Growth | Healthtech, AI, Developer Tools, SaaS | New fund, Oct 2026 | $60M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/ivp-venture-capital-for-the-exceptional/ |
| Sandbox Clinical Ventures | VC firm | Chicago, IL | Seed, Series A, Series B, Growth | Healthtech, Insurtech, AI, Fintech | New fund, Sep 2026 | $100M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/sandbox-clinical-ventures/ |
| Cultivation Capital | VC firm | St. Louis, MO | Seed, Series A, Series B | Healthtech, Biotech, SaaS, Agritech | New fund, Sep 2026 | $100M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/cultivation-capital/ |
| Overlap Holdings | VC firm | Hicksville, NY | Seed, Series A, Series B | Healthtech, AI, Energy, Climate Tech | New fund, Oct 2026 | $16M (SEC Form D, 2023) | 2026-11-04 | https://theinvestordatabase.com/investors/overlap-holdings/ |
| Claritas Signal Partners | VC firm | Nashville, TN | Seed, Series A, Series B, Growth | Healthtech, AI, Media, Developer Tools | New deal, Aug 2026 | $14M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/claritas-signal-partners/ |
| How Women Invest | VC firm | Oakland, CA | Pre-seed, Seed, Series A, Series B | Healthtech, AI, B2B, Climate Tech | New fund, Sep 2026 | $12M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/how-women-invest/ |
| Lightspeed Venture Partners | VC firm | Menlo Park, CA | Seed, Series A, Series B, Growth | Healthtech, AI, Gaming, SaaS | New fund, Jul 2026 | $1.2B (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/lightspeed-venture-partners/ |

You are seeing 25 of 160. The full list adds 135 more investors and 823 named decision-makers.

Get all 160 investors and 823 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/series-b-healthtech-investors
This page: https://theinvestordatabase.com/lists/series-b-healthtech-investors/

## Method and limits
- Source: 69 of the 160 rows carry an SEC filing (Form D or Form ADV). All 160 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states healthtech and digital health as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at Series B.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when Series B is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 160 rows: stage 160, sector 160, fund size 101, website 160. In the paid file: named decision-makers on 147 rows, firm email on 86, LinkedIn page on 114, check size on 39.

## Questions
### How many Series B healthtech investors are there?
We list 160 as of November 2026. 80 of the 160 have a fund filing or a dated deal in the last 12 months.

### Which Series B healthtech investors raised a new fund in the last 12 months?
30 of the 160 have a fund filing dated in the last 12 months. The most recent on this list are IVP: Venture capital for the Exceptional (Oct 2026), True Beauty Ventures (Oct 2026) and Bison Ventures (Oct 2026).

### What is the typical fund size of Series B healthtech investors?
The median fund size on file for this list is $87M, across the 48 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 112 do not disclose a size there.

### How do I contact Series B healthtech investors?
The paid file holds 823 named decision-makers across 147 of these 160 and a firm email for 86. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.

### Where does the data on Series B healthtech investors come from?
69 of the 160 rows have an SEC filing on file (Form D or Form ADV) and 91 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.